Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson's Disease
HanAll Biopharma and Daewoong Pharmaceutical announced that they have entered into a co-development agreement with NurrOn […]
Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer
Topas Therapeutics, a clinical-stage biotech company developing novel antigen-specific immune tolerance therapies to treat autoimmune […]
ISA Pharmaceuticals to Present First Clinical Trial Data of ISA101b and Libtayo® in Head and Neck Cancer
ISA Pharmaceuticals, a clinical-stage biotechnology company developing immunotherapies to treat cancers and serious infectious diseases, […]
Transgene and BioInvent Report Positive Phase Ia Data on Oncolytic Virus BT-001 in Solid Tumors
Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International […]
WHO launching Polio Eradication Campaign in Pakistan using PharmaJet Precision Delivery System
PharmaJet®, a company engineering precision delivery systems that overcome the challenges of vaccine delivery, has […]
FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria
The U.S. Food and Drug Administration (FDA) has approved Xacduro (sulbactam for injection; durlobactam for […]
Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments
Obsidian Therapeutics, a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the […]
MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib in Patients with Acute Myeloid Leukemia or B-Cell Malignancies
MEI Pharma, a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, has announced […]
Antengene Announces Antibody-Drug Conjugate Granted Orphan Drug Designations by the FDA for the Treatment of Gastric and Pancreatic Cancers
Antengene Corporation, a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing […]
BPGbio Announces New Partnership with DoD Focused on AI-Guided Breast Cancer Diagnostics
BPGbio, a leading AI-powered biopharma that focuses on oncology, neurology, and rare diseases, today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more